Cardiac pacemaker are medical device that supply impulses to the conduction system to originate contraction. The first cardiac pacemaker was introduced (Alee and Bernstein, 2001) in 1958, since then cardiac pacing has become a well-established therapeutic tool. Most cardiac pacemakers are inserted in patients above 60 years old and are also utilized in children, involving infants, if necessary. There are various types of conduction block which is most common indication for permanent cardiac pacing. Some leads to Bradycardia, which can result in ventricular dyssynchrony and ineffective ventricular contraction in normal heart rate.

The indications are sent to heart by electrical impulses which helps in producing a heartbeat. There are also some pacemakers which work as per needed. The patient is not allowed to drive a car for a week after insertion of the pacemaker.

Market Dynamics

The increasing need for adoption of cardiac pacemakers, growing trend of medical tourism in Brazil, and increasing adoption of inorganic growth strategies such as mergers, acquisitions, partnerships, and collaborations by key players operating in the market are the major factors that are expected to drive growth of the Brazil cardiac pacemakers market over the forecast period.

Cardiac pacemakers are increasingly used in the Chagas disease, which is highly endemic in 21 countries of Latin America, primarily transmitted by large, blood-sucking reduviid insects widely known as 'the kissing bugs' and by other means such as blood transfusion, organ transplantation, as well as congenital and oral transmissions. For instance, as per stated in National Library of Medicine 25%-30% of cardiac stimulation were performed in 2017 for Chagas disease in Brazil according to Brazil Pacemaker Registry (BPR)

Key features of the study

• This report provides in-depth analysis of the Brazil cardiac pacemakers market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2021–2028), considering 2020 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategies adopted by key players
• It profiles key players in the Brazil cardiac pacemakers market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
• Key companies covered as a part of this study include BIOTRONIK SE & Co.KG, Medtronic plc., Boston Scientific Corporation, Abbott Laboratories, LivaNova plc., Osypka Medical GmbH, MEDICO S.p.A.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The Brazil cardiac pacemakers market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Brazil cardiac pacemakers market.

Market Segmentation

• By Product Type
  • Implantable Cardiac Pacemaker
  • External Cardiac Pacemaker
• By Technology
  • Single Chamber Pacemaker
  • Dual Chamber Pacemaker
  • Biventricular Pacemaker
• By End Users
  • Hospitals
  • Cardiac Clinics
  • Ambulatory Surgery Centers
• Key Players
  • BIOTRONIK SE & Co.KG
  • Medtronic plc.
  • Boston Scientific Corporation
  • Abbott Laboratories
  • Ivanovo plc.
  • Osyka Medical GmbH
  • MEDICO S.p.A